MNMD

Mind Medicine (MindMed) Inc.

7.21 USD
-0.17 (-2.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Mind Medicine (MindMed) Inc. stock is down -13.76% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 May 19:26 16 Jan, 2026 5.00 CALL 75 112
22 May 14:22 21 Jun, 2024 9.00 CALL 525 912
23 May 18:24 20 Sep, 2024 10.00 CALL 275 524
31 May 15:27 16 Aug, 2024 10.00 PUT 130 15
05 Jun 14:27 19 Jul, 2024 8.00 CALL 500 94
05 Jun 14:29 19 Jul, 2024 8.00 CALL 524 94
05 Jun 17:37 20 Sep, 2024 8.00 PUT 150 56
20 Jun 19:49 20 Sep, 2024 8.00 PUT 150 206
21 Jun 14:25 19 Jul, 2024 8.00 CALL 800 1965
21 Jun 14:54 19 Jul, 2024 8.00 CALL 665 1965

About Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc. develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder.

  • Cantor Fitzgerald
    Fri Jun 21, 12:30
    buy
    confirm
  • RBC Capital
    Wed Jun 5, 10:43
    buy
    confirm
  • Baird
    Tue May 28, 16:24
    buy
    initial